Causal associations between both psoriasis and psoriatic arthritis and multiple autoimmune diseases: a bidirectional two-sample Mendelian randomization study

银屑病和银屑病关节炎与多种自身免疫性疾病之间的因果关联:一项双向双样本孟德尔随机化研究

阅读:4

Abstract

BACKGROUND: Numerous observational studies have identified associations between both psoriasis (PsO) and psoriatic arthritis (PsA), and autoimmune diseases (AIDs); however, the causality of these associations remains undetermined. METHODS: We conducted a bidirectional two-sample Mendelian Randomization study to identify causal associations and directions between both PsO and PsA and AIDs, such as systemic lupus erythematosus (SLE), Crohn's disease (CD), ulcerative colitis (UC), multiple sclerosis (MS), uveitis, bullous pemphigoid (BP), Hashimoto's thyroiditis (HT), rheumatoid arthritis (RA), vitiligo, and ankylosing spondylitis (AS). The causal inferences were drawn by integrating results from four regression models: Inverse Variance Weighting (IVW), MR-Egger, Weighted Median, and Maximum Likelihood. Furthermore, we performed sensitivity analyses to confirm the reliability of our findings. RESULTS: The results showed that CD [IVW odds ratio (OR(IVW)), 1.11; 95% confidence interval (CI), 1.06-1.17; P = 8.40E-06], vitiligo (OR(IVW), 1.16; 95% CI, 1.05-1.28; P = 2.45E-03) were risk factors for PsO, while BP may reduce the incidence of PsO (OR(IVW), 0.91; 95% CI, 0.87-0.96; P = 1.26E-04). CD (OR(IVW), 1.07; 95% CI, 1.02-1.12; P = 0.01), HT (OR(IVW), 1.23; 95% CI, 1.08-1.40; P = 1.43E-03), RA (OR(IVW), 1.11; 95% CI, 1.02-1.21, P = 2.05E-02), AS (OR(IVW), 2.18; 95% CI, 1.46-3.27; P = 1.55E-04), SLE (OR(IVW), 1.04; 95% CI, 1.01-1.08; P = 1.07E-02) and vitiligo (OR(IVW), 1.27; 95% CI, 1.14-1.42; P = 2.67E-05) were risk factors for PsA. Sensitivity analyses had validated the reliability of the results. CONCLUSIONS: Our study provides evidence for potential causal relationships between certain AIDs and both PsO and PsA. Specifically, CD and vitiligo may increase the risk of developing PsO, while CD, HT, SLE, RA, AS, and vitiligo may elevate the risk for PsA. Additionally, it is crucial to closely monitor the condition of PsO patients with specific AIDs, as they have a higher likelihood of developing PsA than those without AIDs. Moving forward, greater attention should be paid to PsA and further exploration of other PsO subtypes is warranted.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。